Kenneth Rosenfield, Terry R Bowers, Christopher F Barnett, George A Davis, Jay Giri, James M Horowitz, Menno V Huisman, Beverley J Hunt, Brent Keeling, Jeffrey A Kline, Frederikus A Klok, Stavros V Konstantinides, Michelle T Lanno, Robert Lookstein, John M Moriarty, Fionnuala Ní Áinle, Jamie L Reed, Rachel P Rosovsky, Sara M Royce, Eric A Secemsky, Andrew S P Sharp, Akhilesh K Sista, Roy E Smith, Phil Wells, Joanna Yang, Eleni M Whatley
{"title":"急性肺栓塞患者的标准化数据元素:肺栓塞研究合作组织共识报告》。","authors":"Kenneth Rosenfield, Terry R Bowers, Christopher F Barnett, George A Davis, Jay Giri, James M Horowitz, Menno V Huisman, Beverley J Hunt, Brent Keeling, Jeffrey A Kline, Frederikus A Klok, Stavros V Konstantinides, Michelle T Lanno, Robert Lookstein, John M Moriarty, Fionnuala Ní Áinle, Jamie L Reed, Rachel P Rosovsky, Sara M Royce, Eric A Secemsky, Andrew S P Sharp, Akhilesh K Sista, Roy E Smith, Phil Wells, Joanna Yang, Eleni M Whatley","doi":"10.1161/CIRCULATIONAHA.124.067482","DOIUrl":null,"url":null,"abstract":"<p><p>Recent advances in therapy and the promulgation of multidisciplinary pulmonary embolism teams show great promise to improve management and outcomes of acute pulmonary embolism (PE). However, the absence of randomized evidence and lack of consensus leads to tremendous variations in treatment and compromises the wide implementation of new innovations. Moreover, the changing landscape of health care, where quality, cost, and accountability are increasingly relevant, dictates that a broad spectrum of outcomes of care must be routinely monitored to fully capture the impact of modern PE treatment. We set out to standardize data collection in patients with PE undergoing evaluation and treatment, and thus establish the foundation for an expanding evidence base that will address gaps in evidence and inform future care for acute PE. To do so, >100 international PE thought leaders convened in Washington, DC, in April 2022 to form the Pulmonary Embolism Research Collaborative. Participants included physician experts, key members of the US Food and Drug Administration, patient representatives, and industry leaders. Recognizing the multidisciplinary nature of PE care, the Pulmonary Embolism Research Collaborative was created with representative experts from stakeholder medical subspecialties, including cardiology, pulmonology, vascular medicine, critical care, hematology, cardiac surgery, emergency medicine, hospital medicine, and pharmacology. A list of critical evidence gaps was composed with a matching comprehensive set of standardized data elements; these data points will provide a foundation for productive research, knowledge enhancement, and advancement of clinical care within the field of acute PE, and contribute to answering urgent unmet needs in PE management. Evidence produced through the Pulmonary Embolism Research Collaborative, as it is applied to data collection, promises to provide crucial knowledge that will ultimately produce a robust evidence base that will lead to standardization and harmonization of PE management and improved outcomes.</p>","PeriodicalId":35,"journal":{"name":"Energy & Fuels","volume":null,"pages":null},"PeriodicalIF":5.2000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative.\",\"authors\":\"Kenneth Rosenfield, Terry R Bowers, Christopher F Barnett, George A Davis, Jay Giri, James M Horowitz, Menno V Huisman, Beverley J Hunt, Brent Keeling, Jeffrey A Kline, Frederikus A Klok, Stavros V Konstantinides, Michelle T Lanno, Robert Lookstein, John M Moriarty, Fionnuala Ní Áinle, Jamie L Reed, Rachel P Rosovsky, Sara M Royce, Eric A Secemsky, Andrew S P Sharp, Akhilesh K Sista, Roy E Smith, Phil Wells, Joanna Yang, Eleni M Whatley\",\"doi\":\"10.1161/CIRCULATIONAHA.124.067482\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Recent advances in therapy and the promulgation of multidisciplinary pulmonary embolism teams show great promise to improve management and outcomes of acute pulmonary embolism (PE). However, the absence of randomized evidence and lack of consensus leads to tremendous variations in treatment and compromises the wide implementation of new innovations. Moreover, the changing landscape of health care, where quality, cost, and accountability are increasingly relevant, dictates that a broad spectrum of outcomes of care must be routinely monitored to fully capture the impact of modern PE treatment. We set out to standardize data collection in patients with PE undergoing evaluation and treatment, and thus establish the foundation for an expanding evidence base that will address gaps in evidence and inform future care for acute PE. To do so, >100 international PE thought leaders convened in Washington, DC, in April 2022 to form the Pulmonary Embolism Research Collaborative. Participants included physician experts, key members of the US Food and Drug Administration, patient representatives, and industry leaders. Recognizing the multidisciplinary nature of PE care, the Pulmonary Embolism Research Collaborative was created with representative experts from stakeholder medical subspecialties, including cardiology, pulmonology, vascular medicine, critical care, hematology, cardiac surgery, emergency medicine, hospital medicine, and pharmacology. A list of critical evidence gaps was composed with a matching comprehensive set of standardized data elements; these data points will provide a foundation for productive research, knowledge enhancement, and advancement of clinical care within the field of acute PE, and contribute to answering urgent unmet needs in PE management. Evidence produced through the Pulmonary Embolism Research Collaborative, as it is applied to data collection, promises to provide crucial knowledge that will ultimately produce a robust evidence base that will lead to standardization and harmonization of PE management and improved outcomes.</p>\",\"PeriodicalId\":35,\"journal\":{\"name\":\"Energy & Fuels\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Energy & Fuels\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/CIRCULATIONAHA.124.067482\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/9/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ENERGY & FUELS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Energy & Fuels","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCULATIONAHA.124.067482","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENERGY & FUELS","Score":null,"Total":0}
引用次数: 0
摘要
最近治疗方法的进步和多学科肺栓塞团队的成立为改善急性肺栓塞(PE)的治疗和预后带来了巨大希望。然而,由于缺乏随机证据和共识,导致治疗方法千差万别,影响了新技术的广泛应用。此外,医疗保健领域不断变化,质量、成本和责任越来越重要,这就要求必须对广泛的治疗效果进行常规监测,以全面反映现代肺栓塞治疗的效果。我们着手对正在接受评估和治疗的 PE 患者的数据收集进行标准化,从而为不断扩大的证据库奠定基础,以弥补证据方面的不足,并为急性 PE 的未来治疗提供依据。为此,2022 年 4 月,100 多名国际 PE 思想领袖在华盛顿特区召开会议,成立了肺栓塞研究合作组织。与会者包括医生专家、美国食品和药物管理局的主要成员、患者代表和行业领袖。认识到肺栓塞治疗的多学科性质,肺栓塞研究协作组由来自相关医学亚专科的代表性专家组成,包括心脏病学、肺病学、血管医学、重症监护、血液学、心脏外科、急诊医学、医院医学和药理学。这些数据点将为急性 PE 领域的富有成效的研究、知识提升和临床护理进步奠定基础,并有助于满足 PE 管理中尚未满足的迫切需求。通过肺栓塞研究协作组收集的数据,有望提供重要的知识,最终形成一个强大的证据库,实现 PE 管理的标准化和统一化,并改善治疗效果。
Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative.
Recent advances in therapy and the promulgation of multidisciplinary pulmonary embolism teams show great promise to improve management and outcomes of acute pulmonary embolism (PE). However, the absence of randomized evidence and lack of consensus leads to tremendous variations in treatment and compromises the wide implementation of new innovations. Moreover, the changing landscape of health care, where quality, cost, and accountability are increasingly relevant, dictates that a broad spectrum of outcomes of care must be routinely monitored to fully capture the impact of modern PE treatment. We set out to standardize data collection in patients with PE undergoing evaluation and treatment, and thus establish the foundation for an expanding evidence base that will address gaps in evidence and inform future care for acute PE. To do so, >100 international PE thought leaders convened in Washington, DC, in April 2022 to form the Pulmonary Embolism Research Collaborative. Participants included physician experts, key members of the US Food and Drug Administration, patient representatives, and industry leaders. Recognizing the multidisciplinary nature of PE care, the Pulmonary Embolism Research Collaborative was created with representative experts from stakeholder medical subspecialties, including cardiology, pulmonology, vascular medicine, critical care, hematology, cardiac surgery, emergency medicine, hospital medicine, and pharmacology. A list of critical evidence gaps was composed with a matching comprehensive set of standardized data elements; these data points will provide a foundation for productive research, knowledge enhancement, and advancement of clinical care within the field of acute PE, and contribute to answering urgent unmet needs in PE management. Evidence produced through the Pulmonary Embolism Research Collaborative, as it is applied to data collection, promises to provide crucial knowledge that will ultimately produce a robust evidence base that will lead to standardization and harmonization of PE management and improved outcomes.
期刊介绍:
Energy & Fuels publishes reports of research in the technical area defined by the intersection of the disciplines of chemistry and chemical engineering and the application domain of non-nuclear energy and fuels. This includes research directed at the formation of, exploration for, and production of fossil fuels and biomass; the properties and structure or molecular composition of both raw fuels and refined products; the chemistry involved in the processing and utilization of fuels; fuel cells and their applications; and the analytical and instrumental techniques used in investigations of the foregoing areas.